Aberrant Expression of CD27 and Soluble CD27 (sCD27) in HIV Infection and in AIDS-Associated Lymphoma-Reference-Cited by-同舟云学术

Aberrant Expression of CD27 and Soluble CD27 (sCD27) in HIV Infection and in AIDS-Associated Lymphoma

Published:1999-11 Issue:2 Volume:93 Page:114-123
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Widney Daniel,Gundapp Girija,Said Jonathan W.,van der Meijden Meta,Bonavida Benjamin,Demidem Aisha,Trevisan Cristina,Taylor Jeremy,Detels Roger,Martı́nez-Maza Otoniel

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas;Gruss;Blood,1995

2. Control of lymphocyte function through CD27–CD70 interactions;Lens;Semin. Immunol.,1998

3. Tissue distribution and functional properties of Tp55 (CD27), a novel T cell differentiation antigen;Van Lier;J. Immunol.,1987

4. CD27 expression by a distinct subpopulation of human B lymphocytes;Maurer;Eur. J. Immunol.,1990

5. IgM and IgG but not cytokine secretion is restricted to the CD27 B lymphocyte subset;Maurer;J. Immunol.,1992

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal Fluid and Plasma Concentrations of the Inflammatory Marker Scd27 in a Large Neurologically Healthy Surgical Population;2023

2. Plasma Phage Load is Positively Related to the Immune Checkpoints in Patients Living with Human Immunodeficiency Virus;Current HIV Research;2022-07

3. Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy;Open Forum Infectious Diseases;2022-01-21

4. Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma;Cancers;2021-12-28

5. Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells;Molecular Cancer Therapeutics;2021-06-22